Vanscoy G J, Gajewski L K, Tyler L S, Gora-Harper M L, Grant K L, May J R
Drug Information and Pharmacoepidemiology Center, University of Pittsburgh Medical Center, USA.
Ann Pharmacother. 1996 Jul-Aug;30(7-8):876-81. doi: 10.1177/106002809603000731.
To analyze the current practice of drug information and develop a strategic plan for a "valued" specialty of medication information practice.
The Consortium for the Advancement of Medication Information, Policy, and Research (CAMIPR) met in June 1994 to initiate a strategic plan for a future of medication information practice. A multidimensional situation analysis and strategic planning process was conducted and the results are discussed.
Trends in health care (e.g., healthcare reform, managed care) will impact the future of medication information practice, and the medication information specialist must evolve with society's values. Medication information practice must transform and attention will likely focus on medication policy research/ development and information systems. However, new skills, resources, and relationships must be developed to facilitate this evolution. In addition, interest in the practice of drug information has declined. Strategies are presented to enhance the "value" and "image" of future medication information practice.
分析当前药物信息实践情况，并为药物信息实践这一“有价值”的专业制定战略计划。
药物信息、政策与研究促进联盟（CAMIPR）于1994年6月召开会议，启动了药物信息实践未来的战略计划。开展了多维度形势分析和战略规划过程，并对结果进行了讨论。
医疗保健领域的趋势（如医疗改革、管理式医疗）将影响药物信息实践的未来，药物信息专家必须随着社会价值观的变化而发展。药物信息实践必须转型，注意力可能会集中在药物政策研究/制定和信息系统上。然而，必须开发新的技能、资源和关系以促进这一发展。此外，对药物信息实践的兴趣有所下降。本文提出了提升未来药物信息实践“价值”和“形象”的策略。
